The page is the record's research on the issuer — no analyst, no rating, no view.

NOVACYT S.A. (NCYT) — research page

UK · uk-cm-kg/AIM/NCYT · as of 2026-11-06

Identity and listing

The issuer is NOVACYT S.A., listed on AIM under ticker NCYT, with ISIN FR0010397232 and LEI 213800BWAC2BF295EG28. Its security type is Corporate, its segment is AMSM, its sector is Medical Equipment and Services [201020], and its jurisdiction is France (FR). Its listing status is listed, not halted.

fieldvaluesource · read date
nameNOVACYT S.A.source · 2026-11-06
exchangeAIMsource · 2026-11-06
tickerNCYTsource · 2026-11-06
ISINFR0010397232source · 2026-11-06
LEI213800BWAC2BF295EG28source · 2026-11-09
security typeCorporatesource · 2026-11-06
segmentAMSMsource · 2026-11-06
sectorMedical Equipment and Services [201020]source · 2026-11-06
jurisdictionFrance (FR)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 30 filings in the twelve months to 2026-11-06, across 26 filing days. The median gap between filing days is 9 days, against a median of 7.0 days for AIM and 6 days for the sector. The latest filing is dated 2026-11-02 and is of type corporate action, 4 days before the record date, against a median latency of 4 days for AIM and 2 days for the sector. The record holds 33.5 filings as the median for AIM and 33 as the median for the sector.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer3094
exchange median: AIM (594 issuers)33.574
sector median: Medical Equipment and Services [201020] (17 issuers)3362
datetypecategoryfiling
2026-11-02corporate_actionLiquidity Agreement and Total Voting Rights
2026-09-08regulatory_announcementLaunch of IVDR-Certified Yourgene® DPYD Assay
2026-09-01corporate_actionTotal Voting Rights
2026-09-01regulatory_announcementMaster Collaboration Agreement with Illumina
2026-08-03corporate_actionLiquidity Agreement Update and Total Voting Rights

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Deloitte LLP. The auditor's location is not on the record. Auditor changes are not on the record.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record. The record does not carry a lifecycle type map for this register. The halt flag reads listed, not halted.

Orderability

For elective professional client, the outcome is signal ACM-200, determinable. For eligible counterparty, the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with chapter as of 2026-11-04.

client categoryoutcome
elective professional clientACM-200
eligible counterpartyACM-200

rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

Open research

The record holds 5 openly published research notes. They are from SP Angel Healthcare dated 2021-02-04 and 2020-10-21, from Stifel dated 2017-02-23 and 2016-07-22, and from Invest Securities dated 2016-05-20.

datepublishernotekind
2021-02-04SP Angel HealthcareNovacyt – Update Noteissuer-sponsored
2020-10-21SP Angel HealthcareNovacyt Initiation of Coverageissuer-sponsored
2017-02-23StifelNovacyt SA ALNOV FP BUYindependent
2016-07-22StifelNovacyt SA BUYindependent
2016-05-20Invest SecuritiesNOVACYT (+)independent

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

No years are sealed for the issuer, and the market's vintage is not sealed. The market's earliest sealed date is not on the record. The live record began on 2026-09-11. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of answer is not_sealed.

Sources

15 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
10.2
https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/NCYT (identity.isin)
10.3
https://api.gleif.org/api/v1/lei-records/213800BWAC2BF295EG28 (identity.jurisdiction)
10.4
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5
https://www.londonstockexchange.com/stock/NCYT/novacyt-s-a/company-page (identity.sector)
10.6
https://mcp.uk-cm-kg.ai/events/AIM/NCYT (the disclosure lines)
10.7
https://marketsecurities.fca.org.uk/officiallist (the halt flag)
10.8
https://novacyt.com/wp-content/uploads/2024/09/Novacyt-Annual-Report-and-Accounts-for-the-year-ended-2020.pdf (the auditor)
10.9
https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
10.10
https://novacyt.com/wp-content/uploads/2021/02/SP-Angel-Update-04.02.2021.pdf (open research)
10.11
https://novacyt.com/wp-content/uploads/2022/05/2020_Oct_SP_Angel_Novacyt_Initiation_Note_21.10.2020.pdf (open research)
10.12
https://novacyt.com/wp-content/uploads/2017/05/Stifel-Novacyt-update-23.02.17.pdf (open research)
10.13
https://novacyt.com/wp-content/uploads/2016/07/Stifel-Research-Note-on-Novacyt-22.07.16.pdf (open research)
10.14
http://novacyt.com/wp-content/uploads/2016/06/INVEST-SECURITIES-NOVACYT-research-note.pdf (open research)
10.15
https://mcp.uk-cm-kg.ai/record/AIM/NCYT (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"FR0010397232"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:ddb202017cb3c1de.